NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer NANOBIOTIX (NASDAQ: NBTX) announced first data from the Phase 2 CONVERGE study evaluating JNJ-1900 (NBTXR3) in stage 3 inoperable non-small cell lung cancer, presented March 30, 2026 at the 2026 European Lung Cancer Conference.The poster reports an acceptable safety profile with no serious treatment-emergent adverse events and no adverse impact on patients' ability to continue planned therapy. Initial efficacy in seven patients showed ORR 71.4% and DCR 100%, compared with an estimated benchmark ORR of 45%–50%.

#NBTX NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer

www.stocktitan.net/news/NBTX/nanobiotix-ann...

NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026 NANOBIOTIX (NASDAQ: NBTX) will report its fourth quarter and full year 2025 operational and financial results on March 31, 2026, after U.S. market close. A conference call and webcast will be held on April 1, 2026 at 8:00 AM EDT / 2:00 PM CEST.Laurent Levy, CEO, and Bart van Rhijn, chief financial and business officer, will review year-end results and provide a business update. Webcast replay will be archived on the company website; investors may submit questions in advance via email.

#NBTX NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026

www.stocktitan.net/news/NBTX/nanobiotix-to-...

NANOBIOTIX Statement Regarding Recent Media Speculation NANOBIOTIX (NASDAQ: NBTX) issued a statement on March 25, 2026 addressing recent media speculation about a potential public take-over.The company said, to its knowledge, there is no intention by any party to acquire control and no process or assessment is underway; it also identified factual inaccuracies in the report that conflict with its recent public disclosures.

#NBTX NANOBIOTIX Statement Regarding Recent Media Speculation

www.stocktitan.net/news/NBTX/nanobiotix-sta...

THIS WEEKEND

We’re thrilled to welcome #GREGDULCIE to #HillCountryComicon on March 14-15, 2026!

Greg is known for bringing characters to life such as Smoker in #OnePiece, #MyHeroAcademia, Sidra in #DragonBallSuper, and more!

#voiceactor #NewBraunfelsTX #nbtx #sanantonio #hillcountry

Voting Rights and Shares Capital of the Company Nanobiotix (Nasdaq: NBTX) disclosed its voting rights and share capital as of February 28, 2026. The company reported 48,494,528 shares outstanding, 50,197,214 theoretical voting rights, and 50,175,096 exercisable voting rights.Listing: Euronext Paris and Nasdaq; document explains calculation of gross and net voting rights under AMF rules.

#NBTX Voting Rights and Shares Capital of the Company

www.stocktitan.net/news/NBTX/voting-rights-...

We’re thrilled to welcome #GREGDULCIE to #HillCountryComicon on March 14-15, 2026!

Greg is known for bringing characters to life such as Smoker in #OnePiece, #MyHeroAcademia, Sidra in #DragonBallSuper, and more!

#voiceactor #NewBraunfelsTX #nbtx #sanantonio #hillcountry

Voting Rights and Shares Capital of the Company Nanobiotix (Ticker: NBTX) reported its share and voting-rights counts as of December 31, 2025 in accordance with French disclosure rules.The company shows 48,410,068 shares outstanding and a total theoretical number of voting rights of 50,109,170, with 50,087,052 exercisable voting rights.

#NBTX Voting Rights and Shares Capital of the Company

www.stocktitan.net/news/NBTX/voting-rights-...

How many votes control this French biotech? Nanobiotix reveals tally Nanobiotix files updated share capital notice: 48,401,118 shares and 50,079,581 exercisable voting rights recorded as of Nov. 30, 2025.

#NBTX Voting Rights and Shares Capital of the Company

www.stocktitan.net/news/NBTX/voting-rights-...

NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ Company ’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, today

#NBTX NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris

www.stocktitan.net/news/NBTX/nanobiotix-to-...

https://feliciaray.com/?p=95950  Community toy drive hosted by the New Braunfels MLK Association to collect new, unwrapped toys for children in need this holiday season #nbtx #NewBraunfels #ToyDrive #MLKAssociation #CommunityCare #HolidayGiving #HillCountry New Braunfels MLK Association Toy Drive –

feliciaray.com/reminder-tonight-icc-hol... #tonight #nbtx #FAN Reminder TONIGHT - ICC Holiday Social  

Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook Nanobiotix (NASDAQ: NBTX) reported a third-quarter 2025 operational and financial update and a 2026 clinical outlook. Key items include a $50 million upfront royalty financing with HealthCare Royalty (HCRx) and an expected additional $21 million contingent payment in one year, €20.4 million cash at Sept 30, 2025, and projected cash visibility into early 2028 assuming receipt of HCRx funds. The company completed majority-region sponsorship transfer of the Phase 3 NANORAY-312 head and neck study to Johnson & Johnson, advanced the JNJ-1900 (NBTXR3) program with Phase 1 esophageal data presented, and expanded Curadigm Nanoprimer IP and preclinical work with collaborations and CMC activities.

#NBTX Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook

www.stocktitan.net/news/NBTX/nanobiotix-pro...

#NBTX #d8f12172-624f-4e6b-ab20-e5550efcb84c #investing #Health #Care

Origin | Interest | Match

2 town halls, 1 mission: unite for our community. Join us in New Braunfels or San Marcos. Snacks will be available & 100% of proceeds go towards our local food banks. Can’t make it in person? Join us virtually — & please share to spread the word!

#Unite #Weber2026 #SMTX #NBTX #HillCountryTX

Voting Rights and Shares Capital of the Company NANOBIOTIX (Nasdaq: NBTX / Euronext: NANO) disclosed its voting rights and share capital data as of October 31, 2025. The company reports 48,237,471 shares outstanding, a theoretical total of 50,267,962 voting rights and 50,245,844 exercisable voting rights.The notice follows French disclosure rules (AMF) and explains the difference between theoretical (gross) voting rights and exercisable (net) voting rights, excluding treasury shares. Contact details for communications and investor relations are provided.

#NBTX Voting Rights and Shares Capital of the Company

www.stocktitan.net/news/NBTX/voting-rights-...

NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations NANOBIOTIX (NASDAQ: NBTX) announced progress for its Curadigm Nanoprimer platform on Nov 13, 2025: four new patent applications were filed to expand IP; new in vivo preclinical data presented at PODD 2025 showed the Nanoprimer boosted acute and memory immune responses when combined with mRNA lipoplex and peptide vaccines; numerous material transfer agreements are in place to explore external collaborations; and Chemistry, Manufacturing, and Controls (CMC) activities have been launched to support both an initial proprietary pipeline and partners.Company positions Nanoprimer as a hub for collaborations and internal product development to address extrahepatic IV delivery challenges.

#NBTX NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations

www.stocktitan.net/news/NBTX/nanobiotix-ann...

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth NANOBIOTIX (NASDAQ:NBTX) entered a royalty monetization agreement with HealthCare Royalty (HCRx) providing up to $71 million in non-dilutive capital to fund development of JNJ-1900 (NBTXR3) and next‑wave nanotherapeutics. The company will receive $50 million upfront and may receive an additional $21 million one year post‑closing subject to conditions. Repayment is sourced from a portion of royalties and milestones on the first $1 billion of net sales with a capped return of ~$124M if repaid by end of 2030 (1.75x) or ~$178M thereafter (2.5x).Following the cap, a reduced royalty tail (≤$14.9M/yr) applies for up to 10 years after first US commercial sale. The deal transfers receivables to a French law trust and, assuming full drawdown, extends cash runway into early 2028.

#NBTX NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth

www.stocktitan.net/news/NBTX/nanobiotix-ann...

NANOBIOTIX Announces Updates to JNJ-1900 (NBTXR3) Clinical Program Following Transfer of Ongoing Phase 3 Head and Neck Cancer Trial Sponsorship and Operational Control NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ Company ’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, today

#NBTX NANOBIOTIX Announces Updates to JNJ-1900 (NBTXR3) Clinical Program Following Transfer of Ongoing Phase 3 Head and Neck Cancer Trial Sponsorship and Operational Control

www.stocktitan.net/news/NBTX/nanobiotix-ann...

joeylynn_mesaros
New Braunfels, TX Mayor LAUGHS IN MY FACE when I file an ethics complaint against him.
@joeylynn_mesaros
#corrupt #corruptgovernment #nbtx #newbraunfels #newbraunfelstexas #newbraunfelstx #nbtxlocal
#newbraunfelsliving #comalcounty #texas #expose
June 12
• New Braunfels City Hall

#indivisible #comal #nbtx #nokings

Voting Rights and Shares Capital of the Company NanoBioTix (Nasdaq: NBTX) provided its voting rights and share capital update dated October 15, 2025. The company reports 48,237,471 shares outstanding (as of September 30, 2025) and a total theoretical number of voting rights of 50,318,257 with 50,296,139 exercisable voting rights. Markets: Euronext Paris (Compartment B) and NasdaqEuronext. ISIN: FR0011341205. This notice fulfills disclosure requirements under French commercial and AMF rules regarding the number of shares and voting rights.

#NBTX Voting Rights and Shares Capital of the Company

www.stocktitan.net/news/NBTX/voting-rights-...

Breaking News: ( NASDAQ: #NBTX ) Nanobiotix S.A. (NASDAQ: NBTX) Sees Notable Increase in Wednesday Morning Market Activity

#NewBraunfels #NBTX #FarmersMarket #GrueneWitchApothecary #Herbalism #NatureLovers #HerbalAllies #GreenWitch #GrueneWitch #CottageApothecary #HealthyPlanet #HerbalRemedies #OrganicHerbalWellness #Witchesofinstagram #PlantMedicine #PlantMagic #EathMedicine #Health

NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer Nanobiotix (NASDAQ: NBTX) has announced promising first data from a Phase 1 study of JNJ-1900 (NBTXR3) in patients with locally advanced esophageal adenocarcinoma. The study, conducted at MD Anderson Cancer Center, demonstrated an 85% disease control rate and 69% objective response rate among 13 patients.The treatment, combining JNJ-1900 with chemoradiation, showed strong safety profile and confirmed injection feasibility. Key outcomes include 6 complete responses and 3 partial responses. Of 6 patients who underwent surgery, 2 achieved pathological complete response and 4 showed major pathologic response. The recommended Phase 2 dose was established at 33% of gross tumor volume.The study continues with recruitment of 17 additional patients, exploring both photon and proton chemoradiation combinations.

#NBTX NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer

www.stocktitan.net/news/NBTX/nanobiotix-ann...

NANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial Results Nanobiotix (NASDAQ: NBTX) reported its H1 2025 financial results and business updates, highlighting significant progress in its clinical development program for JNJ-1900 (NBTXR3). The company's revenue increased to €26.6 million, up from €9.3 million in H1 2024, primarily due to a €21.2 million non-cash revenue impact from the J&J agreement amendment.R&D expenses decreased to €14.5 million from €22.0 million, while net loss improved to €5.4 million from €21.9 million year-over-year. Cash position stood at €28.8 million as of June 30, 2025, expected to fund operations into mid-2026. However, the company noted material uncertainty about its going concern status and is in active discussions for non-dilutive financing to extend its cash runway.The company achieved several clinical milestones, including the first patient dosing in the CONVERGE study and data announcements from various Phase 1 trials evaluating JNJ-1900 across different cancer types.

#NBTX NANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial Results

www.stocktitan.net/news/NBTX/nanobiotix-pro...

Stitch Fix Posts Q4 Results, Joins Transocean, MBX Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Bloom Energy (NYSE:BE), Amprius Technologies (NYSE:AMPX) U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Thursday. Shares of Stitch Fix, Inc. (NASDAQ: SFIX) dipped 7.6% to $5.21 in pre-market trading following the release of fourth-quarter results.

Stitch Fix Posts Q4 Results, Joins Transocean, MBX Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session U.S. stock futures were mixed this morning, with the Dow future...

#AMPX #BE #big #losers #CAN #GALT #MBX #NBTX #News #Penny #Stocks

Origin | Interest | Match

50.3 Million Voting Rights: Nanobiotix Reports Updated Share Capital Structure for August 2025 French biotech Nanobiotix (NBTX) discloses 48,236,771 shares outstanding and 50,337,954 theoretical voting rights as of August 31, 2025, with 50,315,836 exercisable rights.

#NBTX Voting Rights and Shares Capital of the Company

www.stocktitan.net/news/NBTX/voting-rights-...

#FallVibes #NewBraunfels #SweaterWeather #CrispAir #AutumnFeels #NewBraunfels #NBTX #FarmersMarket #GrueneWitchApothecary #Herbalism #NatureLovers #PlantLife #GreenWitch #GrueneWitch

50.3 Million Voting Rights: Nanobiotix Reports Latest Capital Structure with 48.2M Shares Outstanding French biotech Nanobiotix announces updated capital structure with 48,236,671 shares and 50,340,736 theoretical voting rights. Company maintains dual listing on Euronext Paris and Nasdaq.

#NBTX Voting Rights and Shares Capital of the Company

www.stocktitan.net/news/NBTX/voting-rights-...

Finally coming over and giving @bsky.app a try!

#popculture #newbraunfels #newbraunfelstx #nbtx #comics #comic #comicbook #comicbooks #supportlocal #comiccreator #independentcomics #indycomics #indiecomics #creatorowned #creatorownedcomics